SIGHT — Gensight Biologics SA Cashflow Statement
0.000.00%
Last trade - 00:00- €26.67m
- €48.07m
- €1.27m
Annual cashflow statement for Gensight Biologics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -30.7 | -34 | -28.6 | -27.6 | -26.2 |
| Depreciation | |||||
| Non-Cash Items | 1.71 | 12.5 | 5.71 | -3.27 | -3.08 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.1 | 5.57 | 4.84 | -3.92 | 2.46 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -28.1 | -15 | -17.1 | -33.8 | -24.7 |
| Capital Expenditures | -0.076 | -0.006 | -0.032 | -0.252 | -0.01 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.026 | -0.37 | 0.016 | 0.424 | 0.219 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -0.102 | -0.376 | -0.016 | 0.172 | 0.209 |
| Financing Cash Flow Items | — | -0.709 | -0.836 | -1.87 | -0.368 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 21.2 | 33.9 | 23.7 | 0.095 | 15.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.99 | 18.7 | 6.35 | -33.7 | -8.48 |